Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 2
Submit an article Journal homepage
1,371
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

E2F transcription factor 1 (E2F1) enhances the proliferation, invasion and EMT of trophoblast cells by binding to Zinc Finger E-Box Binding Homeobox 1 (ZEB1)

Han Gonga Department of Obstetrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaView further author information
,
Fan Lua Department of Obstetrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaView further author information
,
Xiaoling Zenga Department of Obstetrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaView further author information
&
Qing Baib Department of Obstetrics, The Third People’s Hospital of Yunnan Province, Kunming, ChinaCorrespondence[email protected]
View further author information
Pages 2360-2370 | Received 12 Aug 2021, Accepted 23 Dec 2021, Published online: 14 Jan 2022

References

  • Aracil Moreno I, Rodríguez-Benitez P, Ruiz-Minaya M, et al. Maternal perinatal characteristics in patients with severe preeclampsia: a case-control nested cohort study. Int J Environ Res Public Health. 2021;18(22):11783.
  • Opichka MA, Rappelt MW, Gutterman DD, et al. Vascular dysfunction in preeclampsia. Cells. 2021;10(11):3055.
  • Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11(5):309–316.
  • Zárate A, Saucedo R, Valencia J, et al. Early disturbed placental ischemia and hypoxia creates immune alteration and vascular disorder causing preeclampsia. Arch Med Res. 2014;45(7):519–524.
  • Sutton A, Harper LM, Tita A. Hypertensive disorders in pregnancy. Obstet Gynecol Clin North Am. 2018;45(2):333–347.
  • Bagchi S, Weinmann R, Raychaudhuri P. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell. 1991;65(6):1063–1072.
  • Lu G, Li Y, Ma Y, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018;37(1):289.
  • Zheng X, Huang M, Xing L, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19(1):73.
  • Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002;3(1):11–20.
  • Attwooll C, Lazzerini Denchi E, Helin K. The E2F family: specific functions and overlapping interests. EMBO J. 2004;23(24):4709–4716.
  • Singh S, Johnson J, Chellappan S. Small molecule regulators of Rb-E2F pathway as modulators of transcription. Biochim Biophys Acta. 2010;1799(10–12):788–794.
  • Kaitu’u-Lino TJ, Hastie R, Cannon P, et al. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14. Placenta. 2015;36(8):932–937.
  • Li JL, Li R, Gao Y, et al. LncRNA CCAT1 promotes the progression of preeclampsia by regulating CDK4. Eur Rev Med Pharmacol Sci. 2018;22(5):1216–1223.
  • Uchikura Y, Matsubara K, Muto Y, et al. Extranuclear translocation of high-mobility Group A1 reduces the invasion of extravillous trophoblasts involved in the pathogenesis of Preeclampsia: new aspect of high-mobility Group A1. Reprod Sci. 2017;24(12):1630–1638.
  • Shen XY, Zheng LL, Huang J, et al. CircTRNC18 inhibits trophoblast cell migration and epithelial-mesenchymal transition by regulating miR-762/Grhl2 pathway in pre-eclampsia. RNA Biol. 2019;16(11):1565–1573.
  • Davies JE, Pollheimer J, Yong HE, et al. Epithelial-mesenchymal transition during extravillous trophoblast differentiation. Cell Adh Migr. 2016;10(3):310–321.
  • Krebs AM, Mitschke J, Lasierra Losada M, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19(5):518–529.
  • Pedroso MA, Palmer KR, Hodges RJ, et al. Uterine artery Doppler in screening for preeclampsia and fetal growth restriction. Rev Bras Ginecol Obstet. 2018;40(5):287–293.
  • Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2). DOI:10.1161/CIRCOUTCOMES.116.003497.
  • Gao C, Yang H, Increased XF. LINC00922 in preeclampsia regulates the proliferation, invasion, and migration of placental trophoblast cells. Ann Transl Med. 2021;9(20):1553.
  • Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol. 2020;20:S0002-9378(20)31196–0.
  • Schaal CM, Bora-Singhal N, Kumar DM, et al. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer. 2018;17(1):149.
  • Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226.
  • Chaffer CL, San Juan BP, Lim E, et al. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35(4):645–654.
  • Wang Z, Sun X, Bao Y, et al. E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression. Int J Oncol. 2017;51(6):1639–1650.
  • Liang H, Yu T, Han Y, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17(1):119.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.